FDA NDC Directory · JSON-LD · Markdown

XELJANZ

NDC 63539-029 · HUMAN PRESCRIPTION DRUG · SOLUTION

Generic nametofacitinib
Labeler / ManufacturerU.S. Pharmaceuticals
Marketing categoryNew Drug Application (innovator) · App NDA213082
Dosage form / routeSOLUTION · ORAL
Active ingredientsTOFACITINIB CITRATE (1 mg/mL)
Marketing started20210208
Package count1

External sources

Source: openFDA. Public-domain (CC0).